Medicines for dogs from Elanco (above) and Bayer (below) are available in an animal shelter on the treatment table of a veterinarian.Frank Rumpenhorst | picture alliance | Getty ImagesCompany: Elanco Animal Health Inc. (ELAN)Business: Elanco is an…
Buy Kotak Mahindra Bank, target price Rs 2140:…
ICICI Securities has buy call on with a target price of Rs 2140. The current market price of Kotak Mahindra Bank Ltd. is Rs 1986.2. Kotak Mahindra Bank Ltd., incorporated in the year 1985, is…
Buy Bajaj Auto, target price Rs 3130: Kotak…
Kotak Securities has given a buy rating to Bajaj Auto with a target price of Rs 3130. The share price moved down by 0.27 per cent from its previous close of Rs 3034.80. The stock’s…
Buy HDFC Bank, target price Rs 1305: ICICI…
ICICI Securities has given a buy rating to HDFC Bank with a target price of Rs 1305. The share price moved up by 2.09 per cent from its previous close of Rs 1215.50. The stock’s…
Buy Dabur India, target price Rs 540: Yes…
Yes Securities has given a buy rating to Dabur India with a target price of Rs 540. The share price moved up by 0.40 per cent from its previous close of Rs 519.75. The stock’s…
Expect consumer durable stocks to pick up by…
Home appliances will continue to do well and we will potentially see pent-up demand in things like room air conditioners and TV sets, says Mahantesh Sabarad, Head, Retail Research.Is the price action in banks a…
HDFC Bank board approves plan to raise Rs…
New Delhi, Jun 20 () HDFC Bank on Saturday said its board has approved proposal to raise up to Rs 50,000 crore in the next twelve months by issuing various debt securities. The decision was…
Market volatility has vigorously increased retail participation: ICICI…
We have completely transformed ourselves to be a completely all-digital model, says Vijay Chandok, MD & CEO.The lockdown has translated into higher investor activity within the retail space. What is the kind of trend that…
Hold Thyrocare Technologies, target price Rs 541: ICICI…
ICICI Securities has given a hold rating to Thyrocare Technologies with a discounted cash flow-based target price of Rs 541, implying 23 times FY22E earnings and 14.2 times FY22E EBITDA. Thyrocare Technologies’ reported a weak…